Skip to main content
Search
News, Views, and Advocacy From the Oncology Nursing Society
ONS Voice Home
  • News & Views
  • Advocacy
  • Stories
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • News & Views
    • Latest Articles
    • Clinical Practice
    • ONS News
    • ONS Leadership
    Trending Topics
    • Research
    • Treatments
    • Safety
    • COVID-19
    • Drug Reference Sheet
    • Special Populations
    View All Topics
    Advocacy
    • Latest Articles
    • Updates
    • Get Involved
    Stories View All
    View All
    Clinical and Pharmaceutical Nurse Educators Collaborate to Bring Training to Nurses and Improve Patient Care
    Oncology nurse education
    Clinical and Pharmaceutical Nurse Educators Collaborate to Bring Training to Nurses and Improve Patient Care
    January 13, 2023
    Oncology Nurse Uses Retirement to Help Patients and Healthcare Professionals Understand Pancreatic Cancer Biomarker Testing Results
    Pancreatic cancer
    Oncology Nurse Uses Retirement to Help Patients and Healthcare Professionals Understand Pancreatic Cancer Biomarker Testing Results
    November 11, 2022
    The Life of Marie Curie and Her Contributions to Oncology
    Cancer treatments
    The Life of Marie Curie and Her Contributions to Oncology
    November 07, 2022
    Post-Flooding Natural Disaster Cancer Considerations and Patient Education Points
    Patient safety
    Post-Flooding Natural Disaster Cancer Considerations and Patient Education Points
    September 28, 2022
    Can Patients Use Continuous Glucose Monitors During Radiation Therapy for Cancer?
    Radiation therapy
    Can Patients Use Continuous Glucose Monitors During Radiation Therapy for Cancer?
    August 19, 2022
    previous slide
    next slide
    Search
  • News & Views
  • Advocacy
  • Stories
  • Topic

    Patient financial advocacy

    Healthcare Economics Through the Inflation Reduction Act of 2022 and Beyond
    Health Policy

    Healthcare Economics Through the Inflation Reduction Act of 2022 and Beyond

    Sick. Americans are literally sick of the financial burden vulnerable patients endure because of high out-of-pocket, healthcare-related costs. The complicated and convoluted issue has no easy solution.

    January 19, 2023
    The Case of the Costly PARP Inhibitor
    Ovarian cancer

    The Case of the PARP Inhibitor Adherence Assistance

    Mei is a 67-year-old patient who recently underwent an exploratory laparotomy, total abdominal hysterectomy, bilateral salpingo-oophorectomy, omentectomy, and tumor debulking. Her surgical specimens were sent for pathology review and germline biomarker testing. Based on the findings, Mei was diagnosed with stage IIIC, high-grade serous epithelial ovarian cancer with a BRCA1 pathogenic germline variant.

    January 12, 2023
    New Cancer Drugs Launch at Record-High Prices
    Prescription medication

    New Cancer Drugs Launch at Record-High Prices

    Inflating more than 50% since 2017, the annual price of newly launched cancer drugs averages $283,000 in 2022, according to a new report from the office of U.S. Representative Katie Porter (D-CA). Although new drugs for any condition are also seeing record-breaking high prices, the cost of new anticancer therapeutics is 3.7 times higher than that of non-oncology drugs.

    December 14, 2022
    Even During Routine Cancer Care, Financial Hardship Significantly Increases Mortality
    Patient financial advocacy

    Even During Routine Cancer Care, Financial Hardship Significantly Increases Mortality

    Patients with cancer experiencing financial hardship during routine care are nearly 1.5 times more likely to die than those who aren’t, researchers reported in study findings published in JCO Oncology Practice.

    December 13, 2022
    HRSA-Funded Health Centers and NCI-Designated Cancer Centers Partner to Improve Equity in Cancer Screening
    Cancer screening

    HRSA-Funded Health Centers and NCI-Designated Cancer Centers Partner to Improve Equity in Cancer Screening

    The U.S. Department of Health and Human Services, through the Health Resources and Services Administration, awarded more than $5 million in September 2022 to 11 HRSA-funded community health centers to help underserved populations access cancer screenings and early detection services in partnership with National Cancer Institute-designated cancer centers.

    November 30, 2022
    Inflation Reduction Act Lowers Medicare Advantage and Prescription Drug Plan Premiums in 2023
    Patient financial advocacy

    Inflation Reduction Act Lowers Medicare Advantage and Prescription Drug Plan Premiums in 2023

    Under the Inflation Reduction Act, patients will pay lower premiums for the Medicare Advantage and Medicare Part D prescription drug plans during the 2023 coverage year, the Biden-Harris administration announced in September 2022. People with Medicare prescription drug coverage will also receive better and more affordable benefits, including a $35 cost-sharing limit on covered insulin product and coverage for adult vaccines recommended by the Advisory Committee on Immunization Practices.

    November 29, 2022
    Biden-Harris Administration Make Largest Investment Ever in Navigators for 2023 Open Enrollment Period
    Patient financial advocacy

    Biden-Harris Administration Make Largest Investment Ever in Navigators for 2023 Open Enrollment Period

    Making history as the single largest Navigator organization funding award provided to date, the U.S. Department of Health and Human Services, through the Centers for Medicare and Medicaid Services, invested $98.9 million in grant funding to 59 Navigator organizations in August 2022 to help consumers navigate enrollment and make health coverage more accessible.

    November 15, 2022
    CHIP Drastically Reduced Uninsured Children in the Past 25 Years
    Health promotion

    CHIP Drastically Reduced Uninsured Children in the Past 25 Years

    The Children’s Health Insurance Program helped drop the percentage of uninsured children from 15% to 3.7% since its authorization by Congress in 1997, according to data from the U.S. Department of Health and Human Services and the Centers for Medicare and Medicaid Services released in celebration of CHIP’s 25th anniversary in August 2022.

    October 20, 2022
     Senators Cantwell, Grassley Introduce Bipartisan Bill to Battle Unfair Drug Pricing
    Prescription medication

    Senators Cantwell, Grassley Introduce Bipartisan Bill to Battle Unfair Drug Pricing

    Patients with cancer and other healthcare consumers would receive reinforcements in the fight against financial toxicity with new legislation that would “empower the Federal Trade Commission (FTC) to increase drug pricing transparency and hold pharmacy benefit managers (PBMs) accountable for unfair and deceptive practices that drive up the costs of prescription drugs.” U.S. Senators Maria Cantwell (D-WA) and Chuck Grassley (R-IA) introduced the proposed bill in May.

     

    June 29, 2022
    U.S. Supreme Court Dismisses Cases on Medicaid Requirement to Work
    Patient financial advocacy

    U.S. Supreme Court Dismisses Cases on Medicaid Requirement to Work

    A pandemic is not the time to experiment with Medicaid work requirements, the Biden-Harris administration maintained in April 2022 when it urged officials in Arkansas and New Hampshire to cancel their U.S. Supreme Court hearing appeals regarding the Trump administration orders and send the matter back to the U.S. Department of Health and Human Services (HHS) for further action.

    June 01, 2022
    COVID-19 Contributes to Climbing Costs of Cancer Care
    COVID-19

    COVID-19 Contributes to Climbing Costs of Cancer Care

    Cancer is one of the top five most expensive healthcare conditions to treat, costing the United States more than $157 billion annually. The payout from patients’ pockets may be even greater, with the cost of cancer medications alone standing at $895 billion per year. But paying for cancer during a pandemic? Even financially secure patients with healthcare coverage are struggling.

    April 21, 2022
    Even Insured Patients With Advanced Cancer Experience Financial Toxicity
    Patient financial advocacy

    Even Insured Patients With Advanced Cancer Experience Financial Toxicity

    As many as 71% of patients with advanced cancer—most of whom have healthcare insurance—experience major financial hardship because of their disease, according to study findings published in the Journal of the National Cancer Institute.

    March 16, 2022
    CMS Takes Action to Lower Out-of-Pocket Medicare Part D Prescription Drug Costs
    Patient financial advocacy

    CMS Takes Action to Lower Out-of-Pocket Medicare Part D Prescription Drug Costs

    Out-of-pocket prescription drug costs for beneficiaries with Medicare Part D could start to lower with improved price transparency and market competition thanks to a January 2022 proposed rule from the Centers for Medicare and Medicaid Services (CMS). The rule, which would take effect on January 1, 2023, would improve beneficiaries’ experiences with Medicare Advantage and Medicare Part D and work to improve health equity in the programs, according to CMS.

    March 10, 2022
    Marketplace Policy Changes Increase Access for Healthcare Coverage in 2023
    Patient financial advocacy

    Marketplace Policy Changes Increase Access for Healthcare Coverage in 2023

    Consumers will more easily find affordable healthcare coverage in 2023, thanks to the Biden-Harris administration’s December 2021 Notice of Benefit and Payment Parameters 2023 Proposed Rule, according to the U.S. Department of Health and Human Services’ (HHS) Centers for Medicare and Medicaid Services (CMS). The rule also improves shopping for healthcare coverage, establishes rules to ensure people have access to care, and advances health equity for consumers purchasing Marketplace coverage.

    February 24, 2022
    White House Initiative Addresses Disparities for Asian Americans, Native Hawaiians, and Pacific Islanders
    Cancer health disparities

    White House Initiative Addresses Disparities for Asian Americans, Native Hawaiians, and Pacific Islanders

    Advancing equity, justice, and opportunity for Asian American (AA) and Native Hawaiian and Pacific Islander (NHPI) communities in the United States requires an ambitious, whole-of-government agenda, the U.S. Department of Health and Human Services (HHS) announced in December 2021. To drive that agenda, the agency launched the Biden-Harris administration’s White House Initiative on Asian Americans, Native Hawaiians, and Pacific Islanders (WHIAANHPI).

    February 22, 2022
    No Surprises Act Protects Patients From Unexpected Medical Bills
    Patient financial advocacy

    No Surprises Act Protects Patients From Unexpected Medical Bills

    Patients now have protection against unexpected—and often extraordinarily high—medical bills. On January 1, 2022, the Biden-Harris administration’s bipartisan No Surprises Act went into effect to ban surprise billing in private insurance for most emergency care and many instances of nonemergency care, according to the U.S. Department of Health and Human Services (HHS).

    February 09, 2022
    Families See Increase in Healthcare Premiums, Increase in Covered Services
    Patient resources

    Families See Increase in Healthcare Premiums, Increase in Covered Services

    Employer-sponsored health insurance premiums increased by 4% for families in 2021, bringing the average annual cost to $22,221 per family, according to the results of a benchmark Kaiser Family Foundation (KFF) Employer Health Benefits survey released in November 2021. KFF also assessed the COVID-19 pandemic’s impact on workplace health benefits, including telemedicine and mental health services.

    January 13, 2022
    Legislators Want Medicare to Negotiate Drug Prices to Improve Access and Affordability
    Access to Cancer Care

    Legislators Want Medicare to Negotiate Drug Prices to Improve Access and Affordability

    Few political and policy issues resonate with all Americans as much as the costs of prescription medications, particularly those for acute and chronic diseases that affect the body and spirit, like cancer. Seizing the opportunity for real change, in August 2021 President Joe Biden made a major announcement about his administration’s intent to change the dynamic on the financial impact of drugs and government oversight.

    November 18, 2021
    HHS Secretary Releases Proposal to Lower Prescription Drug Costs
    Patient advocacy

    HHS Secretary Releases Proposal to Lower Prescription Drug Costs

    On September 9, 2021, U.S. Department of Health and Human Services (HHS) Secretary Xavier Becerra released the Drug Pricing Plan to combat excessive pricing or prescription drugs and reduce the prices paid by the federal government for such drugs, and to address price gouging in the industry. The plan is a part of an initiative from President Biden’s executive order on Promoting Competition in the American Economy to advance the federal government’s ability to address overconcentration, monopolization, and unfair competition in the economy.

    October 14, 2021
    6.8 Million Individuals Enroll in CHIP Prior to Program’s 24th Anniversary
    Health Policy

    6.8 Million Individuals Enroll in CHIP Prior to Program’s 24th Anniversary

    U.S. Department of Health and Human Services (HHS) Secretary Xavier Becerra celebrated the Children’s Health Insurance Program’s (CHIP’s) 24th anniversary on August 4, 2021, a program that “for more than two decades, has been a lifeline for millions of children and families across America,” with an incredible announcement: in 2020 and 2021, CHIP provided more than 6.8 million enrolled individuals with coverage during the COVID-19 coronavirus pandemic.

    September 15, 2021
    American Rescue Plan Lowers Costs for More Than 1.5 Million Americans During Special Enrollment Period
    Patient financial advocacy

    American Rescue Plan Lowers Costs for More Than 1.5 Million Americans During Special Enrollment Period

    When President Biden signed the American Rescue Plan Act of 2021 into law in March 2021, the administration began working to make improvements in areas such as access and affordability by increasing eligibility for financial assistance. The new law lowered premiums for most people who currently had a Marketplace health plan and expanded access to financial assistance for more consumers, and data published in July 2021 showed that from February 15–June 30, 2021, more than 1.5 million Americans signed up for new health insurance coverage using the 2021 Marketplace Special Enrollment Period (SEP).

    August 31, 2021
    CMS Final Rule Improves Health Equity, Access to Treatment, Hospital Readiness, and More
    Access to Cancer Care

    CMS Final Rule Improves Health Equity, Access to Treatment, Hospital Readiness, and More

    To achieve value-based, person-centered care, the U.S. healthcare system must promote sustainability and readiness to prepare for future public health emergencies such as the COVID-19 coronavirus pandemic, the Centers for Medicare and Medicaid Service (CMS) said. In August 2021, CMS announced that the Hospital Inpatient Prospective Payment System and Long Term Care Hospital Prospective Payment System final rule will take effect on October 1, 2021, in support of that work.

    August 31, 2021
    Biden-Harris Administration Issues Actions to Prevent Surprise Billing
    Patient financial advocacy

    Biden-Harris Administration Issues Actions to Prevent Surprise Billing

    In July 2021, the Biden-Harris administration, through the U.S. Departments of Health and Human Services (HHS), Labor, and Treasury and the Office of Personnel Management, issued the Requirements Related to Surprise Billing interim final rule to restrict surprise billing. The rule applies to billing for patients in job-based and individual health plans who obtain emergency care, nonemergency care from out-of-network providers at in-network facilities, and air ambulance services from out-of-network providers.

    July 19, 2021
    ACA Provides Healthcare Coverage to 31 Million Americans
    Affordable Care Act (ACA)

    ACA Provides Healthcare Coverage to 31 Million Americans

    Approximately 31 million Americans now have healthcare coverage through the Affordable Care Act (ACA), according to a June 2021 issue brief from the office of the assistant secretary for planning and evaluation (ASPE). Of those, 11.3 million consumers were enrolled in Marketplace plans, 14.8 million people were newly enrolled in Medicaid, 1 million individuals were enrolled in ACA’s Basic Health Program option, and nearly 4 million previously eligible adults gained coverage under the Medicaid expansion due to enhanced outreach and increased federal funding. Additionally, insurance rates have fallen across the country since the law’s implementation 11 years ago.

    June 23, 2021
    Patient Advocate Groups Challenge Medicaid Engagement Requirements
    Access to Cancer Care

    Patient Advocate Groups Challenge Medicaid Engagement Requirements

    The American Cancer Society, along with 14 other healthcare groups advocating for increased access to care, filed an amicus curiae—Latin for “friend of the court”—urging the U.S. Supreme Court to deny state imposition of engagement requirements, like monthly community service, for Medicaid beneficiaries. The U.S. Supreme Court is likely to spend spring deliberating and convey a judgment before the end of summer.

    May 14, 2021
    ACA Medicaid Expansion Improves Health and Increases Access to Care for Young Adults
    Affordable Care Act (ACA)

    ACA Medicaid Expansion Improves Health and Increases Access to Care for Young Adults

    The rate of uninsured young adults (aged 19–25) fell by more than one third between 2009 and the first quarter of 2014 following the Affordable Care Act’s (ACA’s) Medicaid expansion, according to a February 2021 report from the Urban Institute. With the expansion, young adults also reported improved overall health, increased access to care, and fewer high out-of-pocket costs. 

    May 12, 2021
    WHO Campaigns for Global COVID-19 Vaccine Equity
    COVID-19

    WHO Campaigns for Global COVID-19 Vaccine Equity

    More than 800 million COVID-19 coronavirus vaccine doses have been administered worldwide. However, 54% of those have been in high-income countries, which contain only 19% of the world’s population, whereas lower-middle income countries have only 33% of the vaccines for their 81% of the population. Those disparities have serious implications and limit equal access to health care, including vaccinations. The World Health Organization (WHO) is campaigning to address vaccine inequity on a global scale. 

    April 21, 2021
    Biden’s American Rescue Plan Targets Social Determinants of Health and Other Disparities
    Cancer health disparities

    Biden’s American Rescue Plan Targets Social Determinants of Health and Other Disparities

    The Biden administration’s American Rescue Plan (APR) is the largest, single piece of legislation focused on economics since Franklin D. Roosevelt proposed in his New Deal programs to pull the United States out of the Great Depression. Sweeping in scope, two of APR’s goals are to make health care accessible for all and to create formal plans for addressing racial disparities. 

    March 23, 2021
    CMS Changes to Medicare Prescription Coverage Could Affect Patient Care
    Access to Cancer Care

    CMS Changes to Medicare Prescription Coverage Could Affect Patient Care

    From Teddy Roosevelt to JFK, presidents throughout history have sent legislation to Capitol Hill with the intent to expand healthcare coverage to more Americans. Finally, when Lyndon B. Johnson drafted a bill and pushed it through Congress by expanding sections of the Social Security Act, Medicare become an entitlement and is now implemented by the Centers for Medicare and Medicaid Services (CMS). During the past 50 years, federal health coverage has grown to include Medicaid, maternal and childcare assistance, public health programs, and prescription medication pricing.

    February 18, 2021
    Providers Challenge Most Favored Nation Model on Drug Pricing
    Prescription medication

    Providers Challenge Most Favored Nation Model on Drug Pricing

    Drug pricing is a bipartisan issue that ranks very high on public opinion polling, and patients with cancer in particular feel the effects of an unregulated market. 

    February 09, 2021
    Billing and Coding Breakdown Helps Nurses Recognize the Realities of Reimbursement
    Patient financial advocacy

    Billing and Coding Breakdown Helps Nurses Recognize the Realities of Reimbursement

    Understanding correct coding strategies is an important skill that affects billing and reimbursement for value-based cancer care. Meeting the requirements for complete and accurate documentation is critical to support healthcare claims. Both nurses and advanced practice providers have responsibilities in this work.

    September 30, 2020
    ONS Bridge

    Oncology Nurses Have a Responsibility to Manage the Financial Toxicities of Cancer

    Cancer is one of the most expensive medical conditions to treat, and patients are expected to pay more and more out of pocket. Costs often lead to financial toxicity, defined as “distress or hardship arising from the financial burden of cancer treatment,” according to Darcy Burbage, DNP, RN, AOCN®, CBCN®, who discussed the topic in a session for the inaugural ONS Bridge™ virtual conference.

    September 10, 2020
    ONS Bridge

    Mylan Patient Specialists Help Support Patients Through Biosimilar Cancer Treatments

    Mylan understands that you care about your patients and that this may be a difficult time for them. Now more than ever, additional treatment options, such as biosimilars offerings may play an important role in providing patients access to medications they need.    

    September 08, 2020
    President Trump Issues Executive Orders on Prescription Drug Pricing
    Patient financial advocacy

    President Trump Issues Executive Orders on Prescription Drug Pricing

    In July 2020, U.S. President Donald Trump issued four executive orders to provide solutions to the ever-increasing price of prescription medications. One of the top domestic issues in healthcare is the price of prescription medication, particularly those deemed lifesaving, such as insulin for diabetics and drugs for patients with cancer. 

    August 10, 2020
    Healthcare Worker Shortage; Trump Clashes With Big Pharma; Surprise Billing
    Nurse staffing

    Healthcare Worker Shortage; Trump Clashes With Big Pharma; Surprise Billing

    Houston, TX, Miami, FL, and Baton Rouge, LA, are three of the many cities battling repercussions from the COVID-19 coronavirus pandemic. Most daunting is the perpetuated shortage of healthcare workers as the pandemic continues to ravage the United States.

    August 03, 2020
    Trump Uses Executive Orders to Lower Drug Pricing
    Prescription medication

    Trump Uses Executive Orders to Lower Drug Pricing

    As one of the only not-entirely-pandemic-related health policy topics currently in policymakers’ discussions, lawmakers are again revisiting the high cost of prescription drugs. Voters have voiced concerns in the current economic climate, and, eager to appease in the months before the November presidential election, the Trump administration responded.

    July 28, 2020
    Nurse-Turned-Policymaker; Prescription Drug Reform; Safer Working Conditions
    Oncology nurse influence

    Nurse-Turned-Policymaker; Prescription Drug Reform; Safer Working Conditions

    As one of the youngest members of the 2018 freshman congressional class, U.S. Representative Lauren Underwood (D-IL) has already made quite a name for herself. Eschewing, for the most part in this heightened environment, partisanship and instead concentrating on health and economic issues, the representative champions access and affordability for all Americans.

    July 27, 2020
    U.S. Cancer Costs Projected to Increase to $245 Billion by 2030
    Access to Cancer Care

    U.S. Cancer Costs Projected to Increase to $245 Billion by 2030

    From 2015 to 2030, the costs associated with cancer will rise to $245 billion, researchers said in a report that was published in Cancer Epidemiology, Biomarkers, and Prevention.

    June 26, 2020
    CMS Grants Waivers to Providers During COVID-19 Public Health Emergency 
    COVID-19

    CMS Grants Waivers to Providers During COVID-19 Public Health Emergency 

    In emergencies such as the COVID-19 coronavirus pandemic, government health agencies have the authority to grant waivers for various federal health programs. Starting on March 23, 2020, the Centers for Medicare and Medicaid Services (CMS) waived certain requirements and protocols for providers and beneficiaries.   

    April 07, 2020
    Prescription Drug Proposal; COVID-19 Safety Legislation; Drug Costs Outpace Inflation
    Health Policy

    Prescription Drug Proposal; COVID-19 Safety Legislation; Drug Costs Outpace Inflation

    Drug pricing is a top legislative issue for Congress, and amid rising COVID-19 concerns, health policy topics are more pressing than ever. On March 5, Senator Martha McSally (R-AZ) introduced the Lowering Prescription Drug Prices for America’s Seniors and Families Act of 2020, which would allow Medicare to negotiate prices after a drug’s patent expires as well as cap out-of-pocket prescription spending for seniors at $3,100 per year.

    March 16, 2020
    How Oncology Nurses Can Support Patients During Financial Toxicity
    Patient financial advocacy

    How Oncology Nurses Can Support Patients During Financial Toxicity

    As groundbreaking yet high-cost cancer treatments make their way into clinical practice, the effects of financial toxicity can put a damper on the profound effects that new, lifesaving medications can have on patients with cancer. It’s a problem that even Washington, DC, hasn’t been able to address—so what can oncology nurses do about it?

    November 12, 2019
    Congress Tackles Surprise Billing for Patient Access to Affordable Care
    Medical reimbursement

    Congress Tackles Surprise Billing for Patient Access to Affordable Care

    A patient is rushed to the emergency room, diagnosed, and taken to surgery immediately. The patient recovers, but weeks later a bill arrives beyond any expectation, and too often ability, to be paid. This practice has become so routine that it has its own name: balance billing or, more commonly, surprise medical billing. It strikes many Americans with the burden of their ailment once again. 

    September 02, 2019
    HHS Announces Safe Importation Action Plan for High Medication Costs
    Health Policy

    HHS Announces Safe Importation Action Plan for High Medication Costs

    The high cost of prescription medications—often lifesaving drugs—has become an unsustainable burden for many American patients. It’s a central topic in the healthcare conversation and a complex issue with countless moving parts. National opinion polling finds that a majority of people want to see changes in drug pricing.

    August 20, 2019
    The Battle Against Drug Pricing Wages On
    Health Policy

    The Battle Against Drug Pricing Wages On

    Few know the power that prescription medications have on the quality of life for patients more than nurses. In more than just physical ways, access to affordable drugs is essential to patient-centered care and emotional, psychological, familial, and even financial stability. For too long, the cost and availability of medicines have been barriers to health care, rather than opportunities for survivorship. 
     

    August 05, 2019
    Chapters Advocate for Patients and Nurses at Statewide Event in Annapolis
    Cancer healthcare advocacy

    Chapters Advocate for Patients and Nurses at Statewide Event in Annapolis

    On March 26, 2019, more than 40 nurses came together at the Maryland General Assembly’s Senate President’s Conference Center for the Oncology Nurses Night in Annapolis. This was the Greater Baltimore Chapter of ONS’s (GBCONS’s) third advocacy trip to the statehouse, but it was the first statewide ONS event. All four Maryland chapters were active in planning the night, and many new advocates were inspired to speak out.

    July 11, 2019
    Healthcare Price Transparency; Cancer Survivor Caucus; Insurers Sue for ACA Backpay
    Health Policy

    Healthcare Price Transparency; Cancer Survivor Caucus; Insurers Sue for ACA Backpay

    Since 2016, then-candidate Trump promised he was going to bring healthcare costs under control. In a White House announcement on June 24, 2019, the president took steps to add transparency to the process by requiring insurance companies, hospitals, and physicians to identify fees and costs in public and simple ways for patients to see in advance and to understand.

    July 01, 2019
    As Drug Pricing Tops Capitol Hill Interest, ONS Advocates for Patient Access to Care
    Prescription medication

    As Drug Pricing Tops Capitol Hill Interest, ONS Advocates for Patient Access to Care

    Reducing the high cost of prescription drugs continues to be a priority focus for both the U.S. Congress and Trump administration, and ONS is closely monitoring and providing input on how key proposals could affect patient access to oncology care.   

    April 22, 2019
    $88 Billion for Healthcare; Raising the Tobacco Age; 2020 Healthcare Push
    Patient financial advocacy

    $88 Billion for Health Care; Raising the Tobacco Age; 2020 Healthcare Push

    According to a Gallup Poll released on April 2, 2019, Americans borrowed approximately $88 billion to pay for health care in 2018. At a National Academies of Science healthcare conference on April 4, the main takeaway was that many Americans surveyed reported that they could not afford to have a serious illness like cancer. The cost of care, even with insurance, is more than many can financially withstand. Oncology nurses know how patients must maneuver through the system to defer costs, sometimes resulting in delayed or alternative approaches to care.

    April 08, 2019
    Dems' Budget Fight; Pharma CEOs Face Congress; Patient Financial Struggles
    Health Policy

    Dems' Budget Fight; Pharma CEOs Face Congress; Patient Financial Struggles

    Democrats control the majority of the House of Representatives, and it’s their responsibility to provide and pass a U.S. budget. As with any Congress, it’s always easier said than done. With a larger, more progressive freshman class interested in pushing more environmental, health, and welfare policy issues forward, costs will be a concern.

    March 04, 2019
    Experts Hold Conversations About Access and Affordability at ONS Policy Summit
    Patient financial advocacy

    Experts Hold Conversations About Access and Affordability at ONS Policy Summit

    Nurses should initiate financial conversations with patients early and offer resources to improve access to cancer care, speakers at the ONS Center for Advocacy and Health Policy’s third annual policy summit on November 13, 2018, concluded. The event, held at the Hyatt Regency Hotel on Capitol Hill in Washington, DC, brought together nurses and industry and government experts to address the issue of financial toxicity in today’s cancer care.

    December 07, 2018
    • Current page 1
    • Page 2
    • Next page
    • Last page Last »
    Trending Topics
    • Research
    • Treatments
    • Safety
    • COVID-19
    • Drug Reference Sheet
    • Special Populations
    • Clinical practice
    • U.S. Food and Drug Administration (FDA)
    • Health Policy
    • Immunotherapy
    View All Topics
     
    Home
    News, Views, and Advocacy From the Oncology Nursing Society
  • Legal Notices
  • Contact Us
  • Conferences
  • Advertising
  • Newsroom
  • Sitemap
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • ONS
  • Oncology Nursing Foundation
  • ONCC
  • © Copyright 2023 Oncology Nursing Society
     
    Back to Top ▲